Cerebras Shares Slide 10% After Record $5.55B IPO
Key insights
- Cerebras raised $5.55B at $185/share, the largest US tech IPO in years, valuing it at $95 billion.
- A 10% first-full-day pullback after a 68% debut pop is consistent with profit-taking patterns in prior high-valuation AI IPOs.
- Cerebras still trades above its $150-$160 IPO range, meaning the correction has not erased debut gains.
Why this matters
Cerebras is the first AI chipmaker of significant scale to go public since the current AI investment cycle began, making its post-IPO trading behavior a live signal for how public markets will price AI infrastructure companies versus the valuations venture capital has assigned them. A sustained pullback would compress multiples across the sector and raise the cost of capital for pre-IPO AI hardware startups planning their own exits in 2026 and 2027. For technical leaders evaluating Cerebras as an Nvidia alternative, public-market pressure also creates new questions about R&D runway and whether the company can sustain the wafer-scale chip investments that differentiate its architecture.
Summary
Cerebras Systems gave investors their first real test of AI chipmaker valuations on public markets, and the answer came back mixed. After a 68% opening-day pop that put the company at a $95 billion valuation, shares pulled back roughly 10% on the first full trading day, a correction that reflects profit-taking rather than any fundamental change in the company's position.
The IPO itself was historic: $5.55 billion raised at $185 per share, the largest US tech IPO in years, priced above an already ambitious $150-$160 range. Even after the pullback, Cerebras trades well clear of that range, meaning early institutional buyers are still sitting on gains.
Essentially: Cerebras is now a public test case for whether the market will sustain $90B-plus valuations for AI infrastructure companies that have not yet demonstrated commensurate revenue scale.
- Cerebras raised $5.55B at $185/share, above its $150-$160 IPO range, valuing it at $95B on debut
- The 10% first-day pullback follows a pattern seen in other high-valuation AI IPOs where early buyers lock in gains immediately
- Shares still trading above IPO price means the correction is noise relative to the structural pricing question
The Cerebras debut sets a live benchmark that every other AI infrastructure company contemplating a public offering will be measured against for the next 12-18 months.
Potential risks and opportunities
Risks
- If Cerebras shares fall below the $185 IPO price within 90 days, underwriters Morgan Stanley and Citigroup face reputational pressure and retail investors who bought at open face losses, potentially cooling appetite for the next wave of AI IPOs.
- A sustained valuation compression could force Cerebras to cut its R&D budget for next-generation wafer-scale chips, ceding ground to Nvidia and AMD at a moment when Cerebras' architectural advantage depends on continued capital investment.
- Lock-up expiration in roughly 180 days will release a large volume of insider shares; if the stock is trading below debut levels at that point, a secondary wave of selling could accelerate a deeper correction and pressure the broader AI chip sector.
Opportunities
- Rival AI chip companies such as Groq and SambaNova can use Cerebras' post-IPO multiple as a reference point to negotiate higher valuations in late-stage private rounds before their own exits.
- Hedge funds and long-only funds that missed the IPO allocation now have a lower-cost entry point to build positions in the only publicly traded pure-play AI wafer-scale chip company.
- Investment banks advising the next cohort of AI infrastructure IPOs (Groq, Cohere, CoreWeave follow-ons) can structure offerings with tighter price-to-revenue discipline to avoid the first-day correction pattern Cerebras exhibited.
What we don't know yet
- Cerebras revenue and gross margin figures for the most recent quarter have not been prominently reported alongside the IPO valuation, making the $95B multiple difficult to contextualize against fundamentals.
- Whether anchor institutional investors who received IPO allocations are selling into strength or holding, and at what price levels selling pressure is concentrated.
- How the G42 strategic partnership (a key Cerebras customer and investor) is structured post-IPO and whether lock-up provisions constrain G42's ability to reduce its position.
Originally reported by cnbc.com
Read the original article →Original headline: Cerebras Stock Falls 10% on First Full Trading Day After Blockbuster $5.55B Nasdaq Debut